F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Source: NYT > U.S. > Politics · Bias: Center Left

Summary

Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

Related Coverage

More Headlines From February 18, 2026

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
NYT > U.S. > Politics

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Center Left

Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine | ParallaxNews.io